“It's not an illness, it's just bad luck”: The impact of anaphylaxis on quality of life in adults

Abstract

Background An increasing number of adults are being diagnosed with anaphylaxis, but its impact on health‐related quality of life (HRQol) is not known. Objective The aim of this study was to explore the impact of anaphylaxis on HRQoL of newly diagnosed adults. Methods Interviews were conducted with 13 adults (aged 40‐71; five males) with anaphylaxis (meeting WAO diagnostic criteria) to drugs, food, venom or spontaneous anaphylaxis, recruited using purposive sampling from allergy clinics in Birmingham, UK. Data were transcribed verbatim and analysed using thematic analysis. Results Four themes were generated from the analysis: the journey from fear to frustration; the need to maintain a healthy identity; control over uncertainty; and the supportive role of others. Participants described their first experiences of anaphylaxis as frightening. Managing the condition was associated with frustration and anxiety, in part due to uncertainty regarding when anaphylaxis might occur. Participants did not consider their allergy as an illness and wanted to retain an identity as a healthy person. They felt a strong need to have control over their anaphylaxis so that it did not take over their lives. The support from others was extremely important, but a lack of understanding of anaphylaxis sometimes hindered that support. Conclusions and Clinical Relevance Anaphylaxis has an adverse impact on the HRQoL of adults irrespective of the cause. More information about anaphylaxis and its management from healthcare professionals may help patients gain a sense of control over their condition and reduce the worry and anxiety associated with it.

Illness perception of adolescents with allergic conditions under specialist care

“…In spite of 82% of participants suffering from food allergy, only 56% included food as the most important factor they believed caused/triggered their allergies. Knibb et al have recently described that patients suffering from anaphylaxis due to hymenoptera venom allergy do not see their food allergies as “a medical condition” but as “isolated” event/s or due to bad luck. We suspect this is one of the reasons behind this response.…”

Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy

“…24 The lack of an immunotherapy for mosquito allergy, or other therapeutic options capable of reducing the risk of analphylaxis for at-risk patients living in mosquito endemic area, could result in a failure of management of risk and QoL, as seen in other allergic conditions. 25 Looking for other drugs targeting the underlying pathophysiology, anti-IgE monoclonal antibody was judged the most suitable choice.…”

Time to act to solve gaps in practice: The BSACI National Allergy Education Strategy

“…Despite the long-recognized health impact of allergy, 1,2 patients and families continue to struggle to access timely, individualized care and support. [2][3][4] There is a paucity of allergy specialists in the UK, [3][4][5] and though much allergy care could be delivered in community settings, few GPs have had any formal training in this area. 6 This means that many patients are under-recognized, undertreated and remain symptomatic.…”